Status:
UNKNOWN
The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Radiotherapy has a significant impact on local control, disease free survival and overall survival in patients with rectal cancer T2, N1, M0 and T3-4, any N, M0. Treatment is accompanied by side effec...
Detailed Description
This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy. In contrast to previous studies, the clinical target vol...
Eligibility Criteria
Inclusion
- patients with rectal cancer scheduled to receive "rectal radiotherapy", pre or postoperative
Exclusion
- No exclusion
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01142713
Start Date
August 1 2010
End Date
December 1 2011
Last Update
June 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TASMC
Tel Aviv, Israel